Well the extensions of deals have to be getting close unless it's in referance to a new larger agreement with one of the existing partners then at has to be either Roche or Mediimune moving forward to the next stage. I guess NAOS really is still in the same position as everyone though only running off anticipated timelines it's all out of the companys control & reliant on the partners. FWIW NAOS's expected developments July/August has been the same since start of year.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.040(2.78%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.46 | $1.40 | $163.1K | 113.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13305 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 3219 | 5 |
View Market Depth
| Last trade - 12.11pm 14/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |